Company / Capital Expenditures
West Pharmaceutical Services Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$285.9M
FY2025
5-year range
$126.4M / $377.0M
FY2021-FY2025
Trend
-24.2%
vs FY2024
Sector context
#36 of 151
Health Care
What the data says
West Pharmaceutical Services's capital expenditures of $286M is higher than 76% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $105M in FY2020 to $377M in FY2024.
Based on SEC 10-K filings.
$286M in FY2025 with a 5-year CAGR of +22.3%. Top quartile in the Health Care sector.
Declined from $362M to $286M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +17.9%
- 5-Year CAGR
- +22.3%
- 10-Year CAGR
- -
Sector benchmark
+5.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +22.3%, indicating consistent growth.
- In FY2025, capital expenditures decreased 24.2% year-over-year.
- Ranks #36 out of 151 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $285.9M | -24.2% |
| FY2024 | $377.0M | +4.1% |
| FY2023 | $362.0M | +107.6% |
| FY2022 | $174.4M | +38.0% |
| FY2021 | $126.4M | +20.7% |
| FY2020 | $104.7M | -17.2% |
| FY2019 | $126.4M | +20.7% |
| FY2018 | $104.7M | -20.0% |
| FY2017 | $130.8M | +16.9% |
| FY2016 | $111.9M | -26.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026